QIP1 inhibitors belong to a distinctive chemical class that plays a crucial role in regulating cellular processes, particularly those involved in the intricate machinery of protein degradation. QIP1, or Quinolone Inhibitor of Proteasome 1, is a protein that interacts with the 20S proteasome, a pivotal component of the cellular proteolytic system responsible for targeted protein degradation. The inhibition of QIP1 entails the disruption of its interaction with the proteasome, leading to altered protein turnover and potentially influencing various cellular functions.
The development of QIP1 inhibitors is grounded in a profound understanding of the intricate molecular mechanisms that govern the ubiquitin-proteasome system, where targeted protein degradation is a finely tuned process crucial for maintaining cellular homeostasis.Chemically, QIP1 inhibitors exhibit a unique structural framework that enables them to selectively interfere with the QIP1-proteasome interaction. This class of inhibitors often features specific molecular motifs that bind to key residues on QIP1, disrupting its binding interface with the proteasome. Through this targeted interference, QIP1 inhibitors have the potential to modulate protein degradation pathways, offering a valuable tool for researchers to dissect the intricate networks that govern cellular protein homeostasis.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent non-selective kinase inhibitor that can affect numerous signaling pathways. It can indirectly affect QIP1 function by inhibiting key kinases in the pathways QIP1 is involved in. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. By inhibiting PI3K, it can affect downstream signaling pathways where QIP1 may play a role. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an ERK pathway inhibitor. It could indirectly affect QIP1 by modifying ERK signaling pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK, a protein involved in multiple signaling pathways. Its inhibition can indirectly influence the function of QIP1. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor. JNK is involved in several cellular pathways which may involve QIP1, thus its inhibition may affect QIP1 indirectly. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is a mTOR inhibitor. mTOR signaling could be a pathway where QIP1 plays a role, and its inhibition can indirectly affect QIP1. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a MEK inhibitor; MEK is upstream of ERK in various signaling pathways. Its inhibition may indirectly influence QIP1's function. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a Rho kinase inhibitor. By inhibiting Rho kinase, it may affect Rho kinase signaling pathway where QIP1 could be involved. | ||||||
PP 1 | 172889-26-8 | sc-203212 sc-203212A | 1 mg 5 mg | $86.00 $145.00 | 6 | |
PP2 is a Src kinase inhibitor. Src kinase is involved in multiple signaling pathways, and its inhibition could indirectly influence QIP1. | ||||||
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | $26.00 | 4 | |
AG490 is a JAK2 inhibitor, which can affect JAK-STAT signaling pathway where QIP1 could be involved. | ||||||